Trade Zoetis - ZTS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.14 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 153.28 |
| Open | 154.89 |
| 1-Year Change | -10.43% |
| Day's Range | 154.89 - 158.18 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | 153.28 | 2.84 | 1.89% | 150.44 | 153.49 | 149.79 |
| Apr 24, 2024 | 150.77 | 1.97 | 1.32% | 148.80 | 151.66 | 148.18 |
| Apr 23, 2024 | 149.47 | 3.58 | 2.45% | 145.89 | 149.83 | 144.54 |
| Apr 22, 2024 | 145.47 | -3.45 | -2.32% | 148.92 | 149.14 | 144.73 |
| Apr 19, 2024 | 146.31 | -2.85 | -1.91% | 149.16 | 151.00 | 145.69 |
| Apr 18, 2024 | 152.95 | 1.60 | 1.06% | 151.35 | 153.54 | 150.28 |
| Apr 17, 2024 | 151.82 | 1.98 | 1.32% | 149.84 | 153.06 | 149.84 |
| Apr 16, 2024 | 152.86 | 3.14 | 2.10% | 149.72 | 154.27 | 148.23 |
| Apr 15, 2024 | 149.69 | -0.19 | -0.13% | 149.88 | 154.75 | 149.11 |
| Apr 12, 2024 | 149.90 | -4.25 | -2.76% | 154.15 | 155.23 | 148.28 |
| Apr 11, 2024 | 162.56 | -0.29 | -0.18% | 162.85 | 163.89 | 161.07 |
| Apr 10, 2024 | 163.12 | -0.76 | -0.46% | 163.88 | 164.70 | 161.90 |
| Apr 9, 2024 | 167.01 | 1.65 | 1.00% | 165.36 | 167.09 | 164.51 |
| Apr 8, 2024 | 165.60 | -0.21 | -0.13% | 165.81 | 166.44 | 163.95 |
| Apr 5, 2024 | 165.77 | 0.14 | 0.08% | 165.63 | 169.06 | 165.02 |
| Apr 4, 2024 | 165.36 | 2.16 | 1.32% | 163.20 | 168.69 | 163.20 |
| Apr 3, 2024 | 162.82 | -1.88 | -1.14% | 164.70 | 166.00 | 162.53 |
| Apr 2, 2024 | 164.85 | 0.03 | 0.02% | 164.82 | 166.10 | 163.05 |
| Apr 1, 2024 | 166.92 | -1.91 | -1.13% | 168.83 | 169.10 | 166.06 |
| Mar 28, 2024 | 169.05 | 0.66 | 0.39% | 168.39 | 171.03 | 166.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Zoetis Company profile
About Zoetis Inc
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company operate its business through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zoetis Inc revenues increased 16% to $7.78B. Net income increased 24% to $2.04B. Revenues reflect International segment increase of 20% to $3.65B, US segment increase of 14% to $4.04B, United States segment increase of 14% to $4.04B, Other emerging markets segment increase of 19% to $778M. Net income benefited from Interest Expense -Gross decrease of 2% to $244M (expense).
Equity composition
Class A Common Stock $.01 Par, 2/13, 5M auth., 86,100,000 issd. Insiders own less than 1%. Class B Common Stock $.01 Par, 1B auth., 413,900,000 issd.
| Industry: | Veterinary Drugs |
10 Sylvan Way
PARSIPPANY
NEW JERSEY 07054
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com